Crinetics Pharmaceuticals, Inc. - Demonstração de Resultados (TTM)

Crinetics Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US22663K1079

Demonstração de Resultados (TTM)

A Demonstração de Resultados de Crinetics Pharmaceuticals, Inc. mostra mudanças na receita e despesas ao longo de um período de tempo. Os dados da Demonstração de Resultados incluem Vendas e Receita, Lucro Bruto, Pesquisa e Desenvolvimento (P&D), Despesas de Vendas, Gerais e Administrativas (SG&A), Renda Operacional, Despesa com Imposto de Renda, Despesa com Juros, Renda Não Operacional, Lucro por Ação (EPS) e Ações em Circulação.

Todos os números são vezes 1,000,000 exceto unidades por ação.

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
Receita 0 0 1 4 5 5 5 4 5 5 4 2 1 1 1 1 1 2 8 18
Mudar (%) NaN 290.45 10.43 9.85 -7.23 -9.54 12.81 -2.32 -15.01 -50.81 -29.84 -24.98 0.00 -26.85 83.16 10.27 401.37 134.78
% da receita 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Custo das vendas 69 76 84 95 107 118 130 140 148 160 169 183 201 219 240 263 285 314 333 357
Mudar (%) 11.49 10.16 12.66 13.18 9.69 10.51 7.84 5.44 8.00 5.37 8.83 9.65 8.98 9.58 9.54 8.35 10.02 6.24 7.22
% da receita 7,815.86 2,255.24 2,311.34 2,307.83 2,749.10 3,277.50 3,063.43 3,387.08 4,199.53 9,290.78 14,520.14 21,094.32 23,114.15 34,612.50 20,475.00 20,428.08 4,328.66 1,976.73
Lucro Operacional Bruto -69 -76 -83 -91 -103 -113 -125 -136 -143 -155 -165 -181 -200 -218 -239 -262 -284 -312 -325 -339
Mudar (%) 11.49 8.76 9.06 13.30 9.68 11.32 8.50 5.21 8.35 5.99 10.28 10.08 9.22 9.62 9.69 8.13 10.02 4.30 4.20
% da receita -7,715.86 -2,155.24 -2,211.34 -2,207.83 -2,649.10 -3,177.50 -2,963.43 -3,287.08 -4,099.53 -9,190.78 -14,420.14 -20,994.32 -23,014.15 -34,512.50 -20,375.00 -20,328.08 -4,228.66 -1,876.73
Vendas, Gerais e Administrativas 21 22 25 28 33 38 42 46 49 52 58 67 78 89 100 114 139 166 191 207
Mudar (%) 7.14 10.85 13.75 17.52 17.38 10.17 8.22 6.22 7.30 11.10 14.87 17.23 13.30 12.52 14.74 21.85 18.91 15.39 8.00
% da receita 2,275.05 662.79 705.34 753.66 894.95 1,070.64 1,008.09 1,107.37 1,447.65 3,380.60 5,648.23 8,530.90 9,599.33 15,057.24 10,017.17 10,802.08 2,486.11 1,143.59
P&D
Mudar (%)
% da receita
OpEx 89 99 109 123 140 156 173 186 197 212 227 250 279 308 340 377 424 479 524 564
Mudar (%) 10.48 10.32 12.91 14.16 11.49 10.43 7.94 5.63 7.83 6.78 10.38 11.67 10.19 10.42 11.06 12.44 12.94 9.40 7.50
% da receita 10,090.91 2,918.03 3,016.67 3,061.50 3,644.06 4,348.14 4,071.51 4,494.45 5,647.17 12,671.38 20,168.38 29,625.22 32,713.47 49,669.74 30,492.17 31,230.16 6,814.77 3,120.32
Lucro operacional -89 -99 -108 -119 -136 -151 -168 -182 -192 -208 -223 -248 -278 -307 -339 -377 -423 -478 -517 -546
Mudar (%) 10.48 9.23 10.13 14.30 11.54 11.02 8.43 5.47 8.09 7.28 11.48 12.00 10.37 10.46 11.18 12.30 12.95 8.15 5.61
% da receita -9,990.91 -2,818.03 -2,916.67 -2,961.50 -3,544.06 -4,248.14 -3,971.51 -4,394.45 -5,547.17 -12,571.38 -20,068.38 -29,525.22 -32,613.47 -49,569.74 -30,392.17 -31,130.16 -6,714.77 -3,020.32
Despesa com juros
Mudar (%)
% da receita
Resultado líquido -89 -98 -108 -119 -136 -150 -164 -175 -184 -199 -215 -235 -259 -278 -298 -328 -370 -423 -465 -496
Mudar (%) 10.71 9.29 10.89 13.64 10.38 9.48 6.94 4.91 8.45 7.57 9.76 9.80 7.49 7.38 10.00 12.67 14.40 9.98 6.68
% da receita -9,985.25 -2,835.99 -2,918.40 -2,932.26 -3,460.38 -4,090.69 -3,804.10 -4,223.27 -5,345.85 -11,928.27 -18,667.15 -26,747.83 -28,720.69 -43,191.05 -26,568.53 -27,563.32 -6,046.22 -2,747.18

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:6Z4 € 30,15
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista